Planet Sleeps, by Sherrilyne Blakey-Smith, The Rankin Family, Hun Sarath w/ Marc Marder, Houria Aichi, Familion, Boukman Eksperyans, Wes, Baluji Shrivastav, Sophie Meriem Rockwell, and Hinewehi Mohi -- $9.98
Johnson & Johnson on Tuesday said its third-quarter profit rose almost 9 percent on better-than-expected sales growth for its array of drugs, medical devices and consumer products.
Minneapolis, MN (PRWEB) October 17, 2006 -- As competition in the pharmaceutical marketplace grows, companies are increasingly looking towards the drug delivery industry to maximize revenues and combat generic competitors.
As competition in the pharmaceutical marketplace grows, companies are increasingly looking towards the drug delivery industry to maximize revenues and combat generic competitors. The search for more efficient drug delivery systems is also being driven by the rise in patient demand, healthcare and pharma cost containment, as much as by medical and technological advances. (PRWeb Oct 17, 2006)
Eisai and Pfizer Inc announced today that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for ARICEPT(R) (donepezil HCl tablets) for treatment of severe Alzheimer's disease (AD). The application was submitted by Eisai Medical Research Inc. (Headquarters: Ridgefield Park, President Mindell Seidlin, MD) on behalf of Eisai Co., Ltd. [click link for
comScore Pharmaceutical Solutions today released the results of an analysis of the behavior and intentions of people who seek cancer-related information online. According to the study, people who research cancer online turn to the Internet predominantly for information on treatment options, which they subsequently validate through discussions with physicians, family or friends. Additionally, more
Pfizer Inc. a world class pharmaceutical company recently broke new grounds in the fight against HIV/AIDS when it recorded the 100th participant in its Global Health Fellows Programme.